ArticleFrontiers in oncology2020

Pictilisib Enhances the Antitumor Effect of Doxorubicin and Prevents Tumor-Mediated Bone Destruction by Blockade of PI3K/AKT Pathway.

Chao Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.